Overview
John Mcgrath-Iii is a Radiation Oncologist practicing medicine in Concord, Massachusetts.
Dr. Mcgrath-Iii is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Classical Hodgkin Lymphoma, and Pleuropulmonary Blastoma.
Dr. Mcgrath-Iii is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
133 Old Road To 9 Acre Cor, Concord, MA 01742
Brigham And Women's Hospital
Brian Alexander is a Radiation Oncologist practicing medicine in Boston, Massachusetts. Dr. Alexander is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Brain Tumor, Glioma, and Tissue Biopsy.
Massachusetts General Hospital
Helen Shih is a Radiation Oncologist practicing medicine in Boston, Massachusetts. Dr. Shih is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Meningioma, Brain Tumor, Astrocytoma, Posterior Fossa Tumor, and Tissue Biopsy. Dr. Shih is currently accepting new patients.
Dana-Farber Cancer Institute, Lowe Center For Thoracic Oncology
Dr. Raymond Mak is an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation, Thoracic Radiation Oncology Disease Site Leader, and Director of Patient Safety/Quality in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.Dr. Mak received his undergraduate degree from Cornell University and medical degree from Harvard Medical School, trained at the Harvard Radiation Oncology Residency Program, and is board certified in Radiation Oncology.Dr. Mak has over 10 years of experience in radiation treatment of thoracic malignancies including lung cancer, mesothelioma, and thymomas, and in the clinical application of advanced radiation therapy techniques including stereotactic body radiation therapy. He has applied stereotactic body radiation therapy for novel indications including the treatment of cardiac arrhythmias. He led the implementation of MR-guided radiation therapy and adaptive radiation therapy program at BWH/DFCI in 2019 and has expertise in these innovative new treatment approaches. His research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients, and applying artificial intelligence techniques to automate radiation therapy planning and improve patient care. He has expertise in developing new methods to reduce the risk of cardiac and pulmonary toxicity for patients receiving radiation therapy. Dr. Mak is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Mak is board certified in Radiation Oncology. Dr. Mak is currently accepting new patients.
Frequently Asked Questions about Dr. John J. Mcgrath-Iii
How do I make an appointment with Dr. John J. Mcgrath-Iii?
You can book an appointment with Dr. John J. Mcgrath-Iii by calling their office at 978-287-3290. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. John J. Mcgrath-Iii a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. John J. Mcgrath-Iii is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. John J. Mcgrath-Iii specialize in?
While Dr. John J. Mcgrath-Iii is a Radiation Oncology, they have specific expertise in Prostate Cancer, Familial Prostate Cancer, and Classical Hodgkin Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.
Does Dr. John J. Mcgrath-Iii accept my insurance?
Dr. John J. Mcgrath-Iii accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 978-287-3290 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Prostate CancerDr. Mcgrath-Iii isDistinguished. Learn about Familial Prostate Cancer.
- Prostate CancerDr. Mcgrath-Iii isDistinguished. Learn about Prostate Cancer.
- Advanced
- Adenoid Cystic CarcinomaDr. Mcgrath-Iii isAdvanced. Learn about Adenoid Cystic Carcinoma.
- Breast CancerDr. Mcgrath-Iii isAdvanced. Learn about Breast Cancer.
- Classical Hodgkin LymphomaDr. Mcgrath-Iii isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Hodgkin LymphomaDr. Mcgrath-Iii isAdvanced. Learn about Hodgkin Lymphoma.
- Pleuropulmonary BlastomaDr. Mcgrath-Iii isAdvanced. Learn about Pleuropulmonary Blastoma.
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Mcgrath-Iii isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- ALK-Positive Non-Small Cell Lung CancerDr. Mcgrath-Iii isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Mcgrath-Iii isExperienced. Learn about EGFR Positive Lung Cancer.
- GliomaDr. Mcgrath-Iii isExperienced. Learn about Glioma.
- Intraductal PapillomaDr. Mcgrath-Iii isExperienced. Learn about Intraductal Papilloma.
- Large-Cell Lung CarcinomaDr. Mcgrath-Iii isExperienced. Learn about Large-Cell Lung Carcinoma.
- Laryngeal CancerDr. Mcgrath-Iii isExperienced. Learn about Laryngeal Cancer.
- Lung AdenocarcinomaDr. Mcgrath-Iii isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Mcgrath-Iii isExperienced. Learn about Lung Cancer.
- Merkel Cell CarcinomaDr. Mcgrath-Iii isExperienced. Learn about Merkel Cell Carcinoma.
- Metastatic Brain TumorDr. Mcgrath-Iii isExperienced. Learn about Metastatic Brain Tumor.
- Nasopharyngeal CarcinomaDr. Mcgrath-Iii isExperienced. Learn about Nasopharyngeal Carcinoma.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Mcgrath-Iii isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Posterior Fossa TumorDr. Mcgrath-Iii isExperienced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Mcgrath-Iii isExperienced. Learn about Primitive Neuroectodermal Tumor (PNET).
- Salivary Gland TumorsDr. Mcgrath-Iii isExperienced. Learn about Salivary Gland Tumors.
- Small Cell Lung Cancer (SCLC)Dr. Mcgrath-Iii isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Mcgrath-Iii isExperienced. Learn about Squamous Cell Lung Carcinoma.
- Throat CancerDr. Mcgrath-Iii isExperienced. Learn about Throat Cancer.
- Thymic Epithelial TumorDr. Mcgrath-Iii isExperienced. Learn about Thymic Epithelial Tumor.
- Tongue CancerDr. Mcgrath-Iii isExperienced. Learn about Tongue Cancer.
